Explore every episode of the podcast ASBMR Speaks

This two-part series is hosted by Dr. Michael McClung, the Founding Director of the Oregon Osteoporosis Center in Portland and an internationally recognized clinician, researcher, and educator in osteoporosis and metabolic bone diseases. Throughout these episodes, he will speak with two pioneers in the osteoporosis treatment field, Socrates Papapoulos and Felicia Cosman. 

These ASBMR members have been critical in harnessing the genetics of high bone mass disorders for their translation into a potent and now widely used anabolic therapy for osteoporosis, romozosumab.

Dr. Felicia Cosman is the Professor of Clinical Medicine at Columbia University College of Physicians and Surgeons who holds a long history of being an investigator in many clinical trials exploring various strategies for the use of osteoanabolic or bone forming therapies for osteoporosis.

This two-part series is hosted by Dr. Michael McClung, the Founding Director of the Oregon Osteoporosis Center in Portland and an internationally recognized clinician, researcher, and educator in osteoporosis and metabolic bone diseases. Throughout these episodes, he will speak with two pioneers in the osteoporosis treatment field, Socrates Papapoulos and Felicia Cosman. 

These ASBMR members have been critical in harnessing the genetics of high bone mass disorders for their translation into a potent and now widely used anabolic therapy for osteoporosis, romozosumab.

Dr. Socrates Popapoulus, Professor of Medicine at the Leiden University Centre for Bone Quality in the Netherlands, joins this episode to discuss his experience in the field, why paying close attention to the patient matters, and much more. 

Our latest series is hosted by Dr. Dolores Shoback, Professor of Medicine at the University of California, San Francisco. Throughout this four part series, we’ll speak with pioneers in the PTH field. We’ll explore basic PTH physiology, actions of PTHrP, PTH for Osteoporosis Treatment and Hypoparathyroidism.

The fourth and final episode of this series features Dr. John Bilezikian, Silberberg Professor of Medicine at the Vagelos College of Physicians and Surgeons at Columbia University. John shares his experience in the field, insights into his career, and some pivotal moments along the way.

Our latest series is hosted by Dr. Dolores Shoback, Professor of Medicine at the University of California, San Francisco. Throughout this four part series, we’ll speak with pioneers in the PTH field. We’ll explore basic PTH physiology, actions of PTHrP, PTH for Osteoporosis Treatment and Hypoparathyroidism.

Episode three features Dr. Benjamin Leder, Professor of Medicine at Harvard University located at Massachusetts General Hospital. Leder shares his beginnings in the field, his experience in clinical research, and much more.

Our latest series is hosted by Dr. Dolores Shoback, Professor of Medicine at the University of California, San Francisco. Throughout this four part series, we’ll speak with pioneers in the PTH field. We’ll explore basic PTH physiology, actions of PTHrP, PTH for Osteoporosis Treatment and Hypoparathyroidism.

Episode two features guest Dr. Natalie Sims, Deputy Director of St. Vincent's Institute in Melbourne, Australia and Professorial Fellow at University of Melbourne. In this episode, we'll explore her experience in research, how data can dictate the direction of a project, advice for early career researchers and more.

Our latest series is hosted by Dr. Dolores Shoback, Professor of Medicine at the University of California, San Francisco. Throughout this four part series, we’ll speak with pioneers in the PTH field. We’ll explore basic PTH physiology, actions of PTHrP, PTH for Osteoporosis Treatment and Hypoparathyroidism.

Episode one features guest Dr. Hank Kronenberg, Endocrinologist at Massachusetts General Hospital and Harvard Medical School. In this episode, we'll dive into his beginnings in the field, his advice for researchers early in their careers, and more.

Our initial series, Pathways: ASBMR Stories of Discovery, is hosted by Dr. Michael Econs, Distinguished Professor at the Indiana University School of Medicine. Throughout this three part series, we speak with pioneers in discovery of FGF23. We explore dysregulation of FGF23 in renal failure, inhibiting FGF23 for treatment of XLH, and the interplay of FGF23 and iron.

Episode three features Dr. Myles Wolf—Professor of Medicine and Chief of Nephrology at Duke University—on the link between iron regulation and FGF23 regulation, what drove his interest in the area, and more.

Be sure to subscribe to tune in for future episodes. Thank you for joining us!

Our initial series, Pathways: ASBMR Stories of Discovery, is hosted by Dr. Michael Econs, Distinguished Professor at the Indiana University School of Medicine. Throughout this three part series, we speak with pioneers in discovery of FGF23. We explore dysregulation of FGF23 in renal failure, inhibiting FGF23 for treatment of XLH, and the interplay of FGF23 and iron.

Episode two features Dr. Kenneth White—Professor of Medical and Molecular Genetics at Indiana University—on his journey through the field, what attracted him to FGF23, and what keeps him going. White also shares his advice for young investigators in the field.

Be sure to subscribe to tune in for future episodes. Thank you for joining us!

Our initial series, Pathways: ASBMR Stories of Discovery, is hosted by Dr. Michael Econs, Distinguished Professor at the Indiana University School of Medicine. Throughout this three part series, we speak with pioneers in discovery of FGF23. We explore dysregulation of FGF23 in renal failure, inhibiting FGF23 for treatment of XLH, and the interplay of FGF23 and iron.

Episode one features a X-linked Hypophosphatemia-focused discussion with Dr. Thomas Carpenter. Dr. Carpenter has maintained a career-long involvement in metabolic bone diseases in children. He currently serves as director of the Yale Center for X-linked Hypophosphatemia (XLH) and as the Medical Director of the Yale Center for Clinical Investigation's Hospital Research Unit. His research interests center on the pathophysiology and development of therapy for XLH, the most common inherited form of rickets. He also has a major interest in the metabolism and function of vitamin D, and disorders related to vitamin D in children. He has published over 200 articles, reviews and chapters with a focus of metabolic bone diseases in children, and is currently an Associate Editor of the Journal of Bone and Mineral Research.

Be sure to subscribe to tune in for future episodes. Thank you for joining us!